ACT Advisors »

Heron Therapeutics shares owned by ACT Advisors

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by ACT Advisors from 13F filings

Historical chart of ACT Advisors investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by ACT Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by ACT Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $51k 26k 1.99
2024-06-30 $78k 22k 3.50
2024-03-31 $61k 22k 2.77
2023-12-31 $38k 22k 1.70

More positions owned by ACT Advisors

Spdr Ser Tr Portfolio S&p400 (SPMD)
Ishares Tr Core S&p500 Etf (IVV)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Invesco Exchange Traded Fd T S&p500 Quality (SPHQ)
Invesco Exch Traded Fd Tr Ii Pfd Etf (PGX)
Spdr Ser Tr Portfolio Ln Tsr (SPTL)
Spdr Ser Tr Bbg Conv Sec Etf (CWB)
Vanguard Index Fds Total Stk Mkt (VTI)
Invesco Exch Traded Fd Tr Ii Short Term Treas (TBLL)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Ishares Tr Msci Usa Min Vol (USMV)
J P Morgan Exchange Traded F Betabuilders Us (BBAG)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)

View all positions for ACT Advisors

Top funds holding Heron Therapeutics

Rubric Capital Management
Vanguard Group
BlackRock
BlackRock
Tejara Capital
State Street Corporation
D. E. Shaw & Co
Palisade Capital Management
Geode Capital Management
JW Asset Management
Clearline Capital
Renaissance Technologies
Orchard Capital Managment
Congress Park Capital
Tang Capital Management

View all funds holding Heron Therapeutics